Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in Chinese Patients With Giant Cell Tumor of Bone
CTR20200538Phase 4Terminated
- Sponsor
- Amgen
- Start
- Jun 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of denosumab in Giant Cell Tumor of Bone (GCTB), sponsored by Amgen. Started Jun 2020; status: terminated.
02
Drugs
denosumab
03
Conditions
Giant Cell Tumor of Bone (GCTB)
Beyond the preview
Go deeper on CTR20200538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200538.